High-mobility group box 1 and cancer

被引:445
|
作者
Tang, Daolin [1 ]
Kang, Rui [1 ]
Zeh, Herbert J., III [1 ]
Lotze, Michael T. [1 ]
机构
[1] Univ Pittsburgh, G27A Hillman Canc Ctr, Inst Canc, DAMP Lab,Dept Surg, Pittsburgh, PA 15213 USA
关键词
HMGB1; Damage associated molecular pattern molecule [DAMP; Autophagy; Cancer; Angiogenesis; Receptor for advanced glycation endproducts [RAGE; TLR2; TLR4; CD24; TLR9; Hallmarks of cancer; Field effect; Inflammation; GLYCATION END-PRODUCTS; SQUAMOUS-CELL CARCINOMA; MOLECULAR-PATTERN MOLECULES; CHROMATIN PROTEIN HMGB1; CISPLATIN-MODIFIED DNA; NUCLEAR FACTOR HMGB1; GROUP-B PROTEINS; BREAST-CANCER; ETHYL PYRUVATE; ESTROGEN-RECEPTOR;
D O I
10.1016/j.bbagrm.2009.11.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High-mobility group box 1 protein (HMGB1), a chromatin associated nuclear protein and extracellular damage associated molecular pattern molecule (DAMP), is an evolutionarily ancient and critical regulator of cell death and survival. Overexpression of HMGB1 is associated with each of the hallmarks of cancer including unlimited replicative potential, ability to develop blood vessels (angiogenesis), evasion of programmed cell death (apoptosis), self-sufficiency in growth signals, insensitivity to inhibitors of growth, inflammation, tissue invasion and metastasis. Our studies and those Of Our Colleagues Suggest that HMGB1 is central to cancer (abnormal Wound healing) and many of the findings in normal Wound healing as well. Here, we focus on the role of HMGB1 in cancer, the mechanisms by which it contributes to carcinogenesis, and therapeutic strategies based on targeting HMGB1. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:131 / 140
页数:10
相关论文
共 50 条
  • [1] The role of high-mobility group protein box 1 in lung cancer
    Wu, Xiao-Jin
    Chen, Yuan-Yuan
    Gong, Chan-Chan
    Pei, Dong-Sheng
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2018, 119 (08) : 6354 - 6365
  • [2] Expression and Effects of High-Mobility Group Box 1 in Cervical Cancer
    Pang, Xiaoao
    Zhang, Yao
    Wei, Heng
    Zhang, Jing
    Luo, Qingshuang
    Huang, Chenglin
    Zhang, Shulan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2014, 15 (05): : 8699 - 8712
  • [3] High-mobility group box 1 protein in endophthalmitis
    Noboru Arimura
    Yuya Ki-i
    Teruto Hashiguchi
    Taiji Sakamoto
    Ikuro Maruyama
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2008, 246
  • [4] High-mobility group box 1: role in ARDS
    A Ishizaka
    S Hashimoto
    Critical Care, 9 (Suppl 1):
  • [5] High-mobility group box 1 in multiple sclerosis
    Sternberg, Zohara
    Sternberg, Daniel
    Chichelli, Trevor
    Drake, Allison
    Patel, Neel
    Kolb, Chana
    Chadha, Kailash
    Yu, Jinhee
    Hojnacki, David
    IMMUNOLOGIC RESEARCH, 2016, 64 (02) : 385 - 391
  • [6] High-mobility group box 1 in multiple sclerosis
    Zohara Sternberg
    Daniel Sternberg
    Trevor Chichelli
    Allison Drake
    Neel Patel
    Chana Kolb
    Kailash Chadha
    Jinhee Yu
    David Hojnacki
    Immunologic Research, 2016, 64 : 385 - 391
  • [7] High-mobility group box 1 protein in endophthalmitis
    Arimura, Noboru
    Ki-i, Yuya
    Hashiguchi, Teruto
    Sakamoto, Taiji
    Maruyama, Ikuro
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (07) : 1053 - 1058
  • [8] The dual role and therapeutic potential of high-mobility group box 1 in cancer
    He, Si-Jia
    Cheng, Jin
    Feng, Xiao
    Yu, Yang
    Tian, Ling
    Huang, Qian
    ONCOTARGET, 2017, 8 (38): : 64534 - 64550
  • [9] The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer
    Chen, Ruochan
    Zou, Ju
    Kang, Rui
    Tang, Daolin
    ANTIOXIDANTS & REDOX SIGNALING, 2023, 39 (7-9) : 569 - 590
  • [10] High-Mobility Group Box-1 and Liver Disease
    Gaskell, Harriet
    Ge, Xiaodong
    Nieto, Natalia
    HEPATOLOGY COMMUNICATIONS, 2018, 2 (09) : 1005 - 1020